HENSON HEIDI
Insider CIK 1283301 · KURA Chief Financial Officer · PRDS Chief Financial Officer · PEPG Director · LSTA Director · CATX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PEPG PepGen Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2026-03-02 | 2026-03-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2026-01-09 | 2026-01-13 | 30,456 | — | $0 | 85,725 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2025-03-03 | 2025-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2025-01-09 | 2025-01-13 | 15,789 | — | $0 | 55,269 | SEC↗ |
| CATX Perspective Therapeutics, | P Buy | 2024-12-04 | 2024-12-06 | 25,975 | $3.85 | $100.0K | 25,975 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2024-06-20 | 2024-06-24 | 23,000 | — | $0 | 23,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2024-01-09 | 2024-01-11 | 19,480 | — | $0 | 39,480 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2023-12-12 | 2023-12-14 | 230,000 | — | $0 | 930,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 125,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 160,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 241,593 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 156,250 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | U Tender | 2023-08-31 | 2023-08-31 | 316,753 | — | $0 | 0 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2023-06-02 | 2023-06-06 | 230,000 | — | $0 | 700,000 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2023-06-02 | 2023-06-06 | 470,000 | — | $0 | 470,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2023-02-01 | 2023-02-03 | 156,250 | — | $0 | 156,250 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2023-01-09 | 2023-01-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2022-09-14 | 2022-09-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2022-05-06 | 2022-05-10 | 11,667 | — | $0 | 11,667 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2022-02-01 | 2022-02-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 81,000 | — | $0 | 81,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2017-01-23 | 2017-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-01-29 | 2016-02-02 | 80,000 | — | $0 | 80,000 | SEC↗ |